Factors involved in treatment decision making for women diagnosed with ductal carcinoma in situ: A qualitative study.


Journal

Breast (Edinburgh, Scotland)
ISSN: 1532-3080
Titre abrégé: Breast
Pays: Netherlands
ID NLM: 9213011

Informations de publication

Date de publication:
Dec 2021
Historique:
received: 11 07 2021
revised: 15 09 2021
accepted: 22 09 2021
pubmed: 9 10 2021
medline: 28 12 2021
entrez: 8 10 2021
Statut: ppublish

Résumé

Whilst some of the diversity in management of women with ductal carcinoma in situ (DCIS) may be explained by tumour characteristics, the role of patient preference and the factors underlying those preferences have been less frequently examined. We have used a descriptive qualitative study to explore treatment decisions for a group of Australian women diagnosed with DCIS through mammographic screening. Semi-structured telephone interviews were performed with 16 women diagnosed with DCIS between January 2012 and December 2018, recruited through the LifePool dataset (a subset of BreastScreen participants who have agreed to participate in research). Content analysis using deductive coding identified three themes: participants did not have a clear understanding of their diagnosis or prognosis; reported involvement in decision making about management varied; specific factors including the psychosexual impact of mastectomy and perceptions of radiotherapy, could act as barriers or facilitators to specific decisions about treatment. The treatment the women received was not simply determined by the characteristics of their disease. Interaction with the managing clinician was pivotal, however many other factors played a part in individual decisions. Recognising that decisions are not purely a function of disease characteristics is important for both women with DCIS and the clinicians who care for them.

Identifiants

pubmed: 34624754
pii: S0960-9776(21)00463-X
doi: 10.1016/j.breast.2021.09.007
pmc: PMC8503564
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

123-130

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Amy Hatton (A)

Cancer Research Program, School of Public Health and Preventive Medicine, Monash University, 553 St Kilda Rd, Melbourne, Victoria, 3004, Australia.

Natalie Heriot (N)

Cancer Research Program, School of Public Health and Preventive Medicine, Monash University, 553 St Kilda Rd, Melbourne, Victoria, 3004, Australia.

John Zalcberg (J)

Cancer Research Program, School of Public Health and Preventive Medicine, Monash University, 553 St Kilda Rd, Melbourne, Victoria, 3004, Australia; Medical Oncology Unit, Alfred Health, 55 Commercial Rd, Melbourne, Victoria, 3004, Australia.

Darshini Ayton (D)

Health and Social Care Unit, School of Public Health and Preventive Medicine, Monash University, 553 St Kilda Rd, Melbourne, Victoria, 3004, Australia.

Jill Evans (J)

BreastScreen Victoria, Australia.

David Roder (D)

Cancer Epidemiology and Population Health, University of South Australia, Australia.

Boon H Chua (BH)

Faculty of Medicine and Health, UNSW Sydney, Australia.

Jolyn Hersch (J)

School of Public Health, Faculty of Medicine and Health, The University of Sydney, Australia.

Jocelyn Lippey (J)

Department of Surgery University of Melbourne, Australia.

Jane Fox (J)

Department of Surgery Monash University, Monash Health Clayton Road Clayton Victoria, Australia.

Christobel Saunders (C)

Department of Surgery, School of Medicine, University of Western Australia, Australia.

G Bruce Mann (GB)

Department of Surgery University of Melbourne, Australia.

Jane Synnot (J)

Consumer Representative Breast Cancer Network Australia, Australia.

Robin J Bell (RJ)

Women's Health Research Program, School of Public Health and Preventive Medicine, Monash University, 553 St Kilda Rd, Melbourne, Victoria, 3004, Australia. Electronic address: robin.bell@monash.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH